This Article Full Text Full Text (PDF) All Versions of this Article: 45/5/914    most recent 01.HYP.0000164567.62172.c5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Veliotes, D. G.A. Articles by Norton, G. R. Search for Related Content PubMed PubMed Citation Articles by Veliotes, D. G.A. Articles by Norton, G. R. Related Collections Remodeling Animal models of human disease Hypertrophy

(Hypertension. 2005;45:914.)
© 2005 American Heart Association, Inc.

Original Articles

Aldosterone Receptor Blockade Prevents the Transition to Cardiac Pump Dysfunction Induced by ß-Adrenoreceptor Activation

Demetri G.A. Veliotes; Angela J. Woodiwiss; Dawn A.J. Deftereos; David Gray; Oleg Osadchii; Gavin R. Norton

From the Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, University of the Witwatersrand Medical School, Johannesburg, South Africa.

Reprint requests to Gavin Norton and Angela Woodiwiss, Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, University of the Witwatersrand Medical School, 7 York Road, Parktown, 2193, Johannesburg, South Africa. E-mail nortongr{at}physiology.wits.ac.za and woodiwissaj@physiology.wits.ac.za

The transition from compensated to decompensated left ventricular hypertrophy (LVH) in hypertension involves excessive ß-adrenoreceptor (ß-AR) stimulation. To explore whether aldosterone receptor activation contributes toward ß-AR–induced left ventricular (LV) decompensation in hypertensive LVH, the effect of spironolactone (SPIRO; 80 mg · kg^–1 · day^–1) on LV cavity dimensions, function, and chamber remodeling mechanisms was evaluated in spontaneously hypertensive rats (SHR) receiving a low dose of the ß-AR agonist isoproterenol (ISO) at 0.02 to 0.04 mg · kg^–1 · day for 4.5 months. ISO administered to SHR resulted in an increased 24-hour urinary aldosterone excretion and LV cavity dimensions, a right shift in LV diastolic pressure-volume relations, a decreased LV relative wall thickness, and increased total, noncross-linked, type I and type III myocardial collagen concentrations without further enhancing increased myocardial norepinephrine (NE) release. ISO reduced pump function without modifying intrinsic myocardial systolic function or inducing further myocyte necrosis or apoptosis. ISO only increased LV cavity volumes after prolonged periods of administration. SPIRO abolished ISO-induced chamber dilatation, wall thinning, and pump dysfunction and reduced total, noncross-linked, type I and type III myocardial collagen concentrations but failed to modify blood pressure, volume preloads, intrinsic myocardial systolic function, myocardial NE release, or the degree of necrosis or apoptosis. In conclusion, these results suggest that aldosterone receptor blockade, through load-independent effects, may be useful in preventing the transition from compensated LVH to dilatation and pump dysfunction mediated by chronic ß-AR activation.

Key Words: remodeling • collagen • sympathetic nervous system • aldosterone

This article has been cited by other articles:

				O. H.I. Majane, L. Vengethasamy, E. F. du Toit, S. Makaula, A. J. Woodiwiss, and G. R. Norton Dietary-Induced Obesity Hastens the Progression From Concentric Cardiac Hypertrophy to Pump Dysfunction in Spontaneously Hypertensive Rats Hypertension, December 1, 2009; 54(6): 1376 - 1383. [Abstract] [Full Text] [PDF]

				E. F. du Toit, W. Smith, C. Muller, H. Strijdom, B. Stouthammer, A. J. Woodiwiss, G. R. Norton, and A. Lochner Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2336 - H2343. [Abstract] [Full Text] [PDF]

				G. R. Norton, D. G. A. Veliotes, O. Osadchii, A. J. Woodiwiss, and D. P. Thomas Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H372 - H378. [Abstract] [Full Text] [PDF]

				B. Pitt Promise of Mineralocorticoid Receptor Blockade in Asymptomatic Left Ventricular Dysfunction Hypertension, September 1, 2007; 50(3): 461 - 462. [Full Text] [PDF]

				O. E. Osadchii, G. R. Norton, R. McKechnie, D. Deftereos, and A. J. Woodiwiss Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1898 - H1905. [Abstract] [Full Text] [PDF]